TRS

Several events impacted TriMas Corp.'s stock from April to October 2026. The divestiture of the Aerospace business in March 2026 allowed the company to focus on packaging and life sciences, resulting in a strong balance sheet with $846 million net cash by Q2 2026. The company actively repurchased shares, buying 509,264 shares for $18.9 million in Q2 2026 and nearly 2 million shares for $73.5 million year-to-date through June 30, 2026, reducing outstanding shares by 4.7%. Since November 2025, over five million shares have been repurchased. In Q2 2026, TriMas reported net sales up 1.6% year-over-year to $174.6 million, with adjusted EPS of $0.52 beating estimates, though revenue missed, causing an 8.26% premarket stock drop. Despite this, operating profit surged 29%, and full-year adjusted EPS guidance was raised. The company also announced its Q3 2026 earnings conference call for October 5, 2026. Over the last year, TriMas's stock price increased by 2.88%, trading at $38.44 as of October 7, 2026, within a 52-week range of $30.43 to $45.43.